Regeneron Pharmaceuticals reported $6.57B in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
AbbVie USD 13.82B 1.34B Jun/2026
Agenus USD 22.34M 107K Mar/2026
Agios Pharmaceuticals USD 24.22M 8.08M Jun/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
Amgen USD 10.35B 126M Sep/2026
Astellas Pharma JPY 825.78B 19.03B Sep/2026
AstraZeneca USD 18.87B 11M Sep/2026
Biogen USD 2.38B 15.8M Sep/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
Incyte USD 1.24B 111.82M Sep/2026
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
J&J USD 19.05B 3.49B Jun/2026
Kyowa Hakko Kirin JPY 143.12B 10.18B Sep/2026
Merck USD 12.56B 354M Jun/2026
Moderna USD 1.37B 1.35B Sep/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Novartis USD 9.96B 109M Sep/2026
Novartis USD 9.96B 361M Sep/2026
Pfizer USD 17.57B 1.38B Sep/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
Sarepta Therapeutics USD 385.98M 7.82M Sep/2026
Teva Pharmaceutical Industries USD 3.84B 344M Sep/2026
Ultragenyx Pharmaceutical USD 200M 140M Jun/2026
United Therapeutics USD 348.6M 38.3M Sep/2026
Vertex Pharmaceuticals USD 2.31B 176.7M Sep/2026